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The aim of this study was to develop a scale to assess the levels of specific self-efficacy
in order to enhance adherence to a gluten-free diet and the life quality of celiac patients.
Celiac disease is a chronic small intestinal immune-mediated enteropathy precipitated by
exposure to dietary gluten in genetically predisposed people. The only treatment is a strict
lifelong gluten-free diet. Within the framework of Social Cognitive Theory, expectation of
self-efficacy is understood as the degree in which a person believes himself to be capable
of performing a certain task (e.g., adhering to a gluten-free diet), a construct which has
been widely studied in its relation with adopting healthy behaviors, but scarcely in relation
to celiac disease. A validation study was carried out in various stages: preparation of the
protocol; construction of the questionnaire and a pilot run with 20 patients; validation
of the scale with 563 patients and statistical analysis. A 25-item scale was developed.
Feasibility was excellent (99.82% of participants completed all the questions). Factorial
analysis pointed to the existence of five factors that explained 70.98% of the variance
with a Cronbach alpha of 0.81 for the scale overall and between 0.64 and 0.90 for
each factor. The scale showed a Spearman’s Rho coefficient of 0.279 with the General
self-efficacy Scale. This easily administered scale provides good psychometric properties
for evaluating specific self-efficacy of celiac patients in adhering to treatment. It seeks to
be the first scale that provides not only a measurement of specific self-efficacy in celiac
disease, but also to determine its levels for each of the areas as a first step toward
designing interventions of self-management and empowerment programs to cope with
the disease.
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INTRODUCTION
Celiac disease (CD) is a chronic small intestinal immune-mediated enteropathy precipitated by
exposure to dietary gluten in genetically predisposed people (Ludvigsson et al., 2013). Numerous
studies report a prevalence of between 1:67 and 1:250, for the USA and Europe (Leffler et al., 2008),
while 1:100 is a widely accepted figure (Catassi et al., 2007). The only valid treatment known
today is a lifelong strict gluten-free diet (GFD). Despite the benefits of a GFD, rates for strict
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adherence range from 42 to 91% depending on definition and
method of assessment (Hall et al., 2009).
Within Social Cognitive Theory, Bandura defines self-efficacy
as “beliefs in one’s capabilities to organize and execute the course
of action required to produce given attainments” (Bandura,
1997, p.3). Thus, the expectation of self-efficacy has been widely
studied in many spheres such as physical activity (Schwarzer
et al., 2008), tobacco addiction (Hendricks et al., 2010), multiple
sclerosis (Chiu et al., 2011), or patients with arthritis (Lorig
et al., 2014). However, it has received scant attention for celiac
disease (Ford et al., 2012). High levels of self-efficacy are related
to the perception of well-being and adherence to healthy eating
(Luszczynska et al., 2005). Recently, self-efficacy has been linked
to better adherence to GFD and better quality of life in celiac
patients (Ford et al., 2012).
Qualitative studies show that celiac patients have to cope with
problems mainly in five areas: eating in the workplace, shopping,
traveling, eating out, and eating at home with others (Sverker
et al., 2005). These difficulties can lead to negative emotions and
affect relationships. Celiac patients with low self-efficacy can find
eating and drinking situations potentially stressful and, hence, are
not able to keep to their GFD in such circumstances, or if they are
able to, it is at the cost of a lower life quality (Leffler et al., 2008).
There are a few questionnaires aimed to evaluate self-efficacy
in a general way: Sherer’s General Self Efficacy Scale (Sherer
et al., 1982), recently translated into Spanish and validated
(Herrero et al., 2014), Schwarzer’s General Self Efficacy Scale
(Schwarzer and Jerusalem, 1995), and the New General Self
Efficacy Scale (Chen et al., 2001). All three scales provide solid
psychometric information (Scherbaum et al., 2006) but none of
them provide a specific measure of self-efficacy. Bandura (1997)
emphasizes the convenience of specifically evaluating self-efficacy
expectation and in a way that is closely linked to the demands
of a particular situation, rather than making general evaluations
of that situation. We have not found any scale to assess specific
self-efficacy in celiac patients.
More recently, Schwarzer has proposed the Health Action
Process Approach (HAPA model) as an explanatory framework
for adherence to healthy habits (Schwarzer et al., 2011) in which
self-efficacy plays a key role.
Traditional explanatory models of change fail to explain
the gap between intention and action. The HAPA model
distinguishes between pre-intentional motivational process and
post-intentional volitive processes that lead to healthy habits. We
think that this model is useful to explain adherence to GFD.
The HAPA model is described in two-phases: a pre-intentional
motivational and a post-intentional volitional phase. It is in the
initial motivational phase, when the individual still needs to
develop the intention to acquire a healthy habit (e.g., adherence
to a GFD). In this phase, risks are seen as threatening but unlikely,
especially by asymptomatic patients, and not important enough
to build an intention. Conversely, they are important enough
to motivate the patient toward a contemplation stage for the
evaluation of the capabilities needed to take up a GFD (social
skills, facing temptations, etc.) and negative consequences (giving
up to certain foods, changing habits or extra work associated
with the diet). In the same manner, positive consequences are
important at this motivational phase (for example, a healthier
diet or symptomatology improvement). According to this model,
in this phase, high self-efficacy beliefs, together with positive
outcome expectations, play a major role and both are necessary
to develop an intention. But the development of an intention is
not enough. Once developed, in a second phase, this intention
needs to be turned into action and, finally, into a strict adherence
for which self-regulation skills and strategies are required. In
this volitional phase, planning, and self-efficacy beliefs to face
transgression play a central role.
Using this model, we developed a scale to assess specific self-
efficacy as a determinant in adherence to GFD and subsequently
be able to investigate its impact on the quality of life in celiac
patients.
METHODS
A multi-phase prospective, observational study was designed
in various stages (Grau, 1995): preparation of the protocol,
construction of the questionnaire, and pilot run and validation
of the questionnaire.
Phase 1: Preparation of a Protocol
Prior to the study, the research team drew up a protocol (Fueyo-
Díaz et al., 2015). The study population was celiac patients who
had been prescribed a lifelong GFD. A minimum age of 12
years was fixed as this is the age at which primary education
ends and adolescents starting secondary education have to start
managing their diet on their own. It is also assumed that by this
age the patient has acquired sufficient language skills to be able
to understand and reply to the questionnaire. A sample size of
10–15 patients per item was estimated as appropriated for the
validation phase (Kline, 1998).
Phase 2: Construction of the Scale and
Pilot Study
The research team created an initial questionnaire based on
the Spanish version of the General Self-Efficacy Scale (GSES)
(Baessler and Schwarzer, 1996) and follow the recommendations
for constructing this type of scale (Bandura, 2006). This first
questionnaire contained 80 questions, distributed in the areas
identified by Sverker: (1) Shopping: the celiac patient can often
experience problems with labels or when asking for gluten-free
products over the counter, etc. (2) Travel: how they cope with the
diet when using a foreign language or in a place where customs
are different, etc. (3) Eating at home with others: this section
aims to evaluate those situations in which the behavior of others
has to be corrected when this may suppose a risk, identifying
oneself as a celiac sufferer and not seeming brusque or rude
when refusing food offered by others. (4) Eating out: this section
examines aspects such as rejecting dishes that might not be safe.
(5) Eating in the workplace or at school: here, social situations at
work are explored, such as finding gluten-free options at business
or school celebrations.
The initial questionnaire was then analyzed by a team of
experts in celiac disease comprising researchers, physicians,
psychologist, dietitians and patients. The number of items was
Frontiers in Psychology | www.frontiersin.org 2 March 2018 | Volume 9 | Article 342
Fueyo-Díaz et al. Celiac-SE: Self-Efficacy Scale for GFD
whittled down to the 40 most significant. In order to analyze the
face and construct validity, the new version of the questionnaire
was then studied and assessed by a second team of experts. The
opinions and comments of the experts helped to add, remove, or
clarify the items and to decide on their inclusion in the definitive
scale. After this second team of experts the number of items
remained unaltered with 40 items. The scale was constructed to
allow responses for all items from 0 (not at all able) to 10 (totally
able) in order to evaluate the degree of self-efficacy respondents
experienced in each of the situations proposed. To get both the
scale and subscale scores we took the mean value of the answers.
Although 99.82% of participants completed all the questions,
missing data were completed with the mean value obtained by
the rest of the subjects in the missed particular item. In clinical
settings, although we recommend to use only completely filled
questionnaires, missing values can be substituted by the mean
in the subscale. A pilot study of the new version was carried out
with 20 patients to check the relevance and comprehension of the
questions selected.
Phase 3: Questionnaire Validation
The study was advertised through patients’ associations and
invitations to participate were sent out to their associates.
The questionnaire was administered on line alongside the
Spanish adaptation of the GSES (Baessler and Schwarzer, 1996).
Along with these items, we incorporated sociodemographic
variables on place of residence, the year of diagnosis, time on
GFD, and age.
The questionnaires were completed anonymously and then
returned to the research team. The questionnaire returned two
types of measurements: an overall score for the questionnaire
and scores for each of the five areas, so enabling the evaluation
of specific self-efficacy in each of the areas analyzed.
The questionnaires were collected between June and
September 2014.
Phase 4: Statistical Analysis
Construct validity was determined by factorial analysis (principal
components with a VARIMAX rotation) based on eigenvalues
>1 criterion (Kleinbaum et al., 1978). We included the necessary
factors to obtain a capacity to explain approximately a 70% of
the variance. The relevance of the factorial analysis was evaluated
using a correlation matrix among the variables, the Barlett
sphericity test to study the identity of the correlation matrix
and the Kayes, Meyer, and Olkin statistic to measure sample
suitability.
Concurrent validity was calculated with Spearman’s Rho
coefficient with the GSES scale for each of the areas and for the
questionnaire as a whole while the Cronbach alpha was used
to study overall reliability of the questionnaire and for each of
the scales. Multiple comparisons were performed by one-way
ANOVA and post-hoc evaluations by Scheffe’ test. Kruskal–Wallis
andUMann–Whitney tests were performed when necessary. The
SPSS v.21 program was used for the statistical analysis and 0.05
was taken as being statistically significant throughout.
This study was approved by the Aragon Scientific
Research Ethics Committee (CEICA), registered under
TABLE 1 | Characteristics of participants.
Variable
Sex (% female) 77.8
Age % (<18/18-35/36-65/>65) 13.5/29.8/55.2/1.4
Years on GFD (<1/1-3/4-5/<4 6.4/23.9/14.6/55
% Member of patients’ association 97.8
number PI 14/0011. The research team obtained written
and informed consent from the participants, or their legal
guardians.
RESULTS
Participants
Five hundred and sixty-three valid 40-item questionnaires were
collected. Patients were aged from 12 to 72 years (M: 37.37;
SD: 13.80) and 77.8% were females. Age at diagnosis ranged
from 1 to 69 (M: 28.15; SD: 15.26). Patients had been following
a GFD from <1 year to 59 (M: 8.77; SD: 8.74) (Table 1).
Feasibility was excellent, 99.82% of participants completed all
the questions. There was no floor effect, and ceiling effect was
low (3.9%).
Study of the Suitability of the Factorial
Analysis
The relevance of the factorial analysis was evaluated using
a correlation matrix among the variables. The associated p-
value for the Barlett Sphericity Test was p < 0.001, indicating
that there was, indeed, a relation between the items, which
was a guarantee of the technical suitability of the factorial
analysis. Finally, the KMO value was 0.934, which is well
above the recommended 0.75. The obtained results showed that
there was enough support to perform the pertinent factorial
analysis.
Determination, Extraction, and
Interpretation of Factors
Prior to the final factorial analysis, items that fulfilled the
following criteria were eliminated: (1) any item that had >5%
missing data; (2) any item that correlated poorly with the total
scale (i.e., item-to-total correlation <0.40) and thus measured
a different construct; (3) pairs of redundant items (i.e. an item-
item correlation >0.75). The final questionnaire comprised 25
of the original 40 questions. These were grouped in five areas
(Table 2).
Since the factorial analysis was confirmatory, we forced the
model to extract five factors, explaining 70.98% of the total
variance. The rotated components matrix (Table 2) shows the
coefficients associated to each item, and its area or factor after
a VARIMAX rotation.
The matrix shows the following structure: factor 1, “eating
out,” explains 43.23% of the variance; factor 2, “traveling” explains
9.57% of the total variance; factor 3, “eating at home with others”
8.60% of the variance; factor 4, “shopping,” accounts for 4.97%
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TABLE 2 | Rotated components matrix.
Items Factor 1 Factor 2 Factor 3 Factor 4 Factor 5
SHOPPING
1. When I have to ask people to clean machines, utensils or surfaces, for example at the butcher’s. 0.405 0.259 −0.107 0.370 0.195
2. When shopping I have to reject a product that may not be safe for me. 0.131 0.218 −0.061 0.613 0.164
3. When I have to resist buying something that looks very appetizing but may contain gluten. 0.045 0.163 0.292 0.685 0.119
4. My belief in my ability to adhere to the recommendations of doctors and associations when
shopping is …
0.180 0.220 0.240 0.631 0.047
TRAVELING
5. When I’m traveling and I have to find a gluten-free meal and I have not brought my own food. 0.239 0.802 0.029 0.098 0.317
6. When I’m traveling in places I know and I have find a gluten-free meal and I have not brought my
own food.
0.262 0.785 0.068 0.114 0.246
7. When I have to find a gluten-free meal when traveling in unknown places and I have not brought
my own food.
0.245 0.833 0.047 0.090 0.237
8. When I travel abroad but speak the language and have not brought my own food. 0.243 0.838 0.034 0.075 0.187
9. My confidence in not abandoning my gluten-free diet when visiting a city and I want to go to
restaurants sample the typical food there…
0.046 0.660 0.278 0.320 −0.055
10. When I’m traveling and I have to find a gluten-free meal and I have not brought my own food. 0.076 0.653 0.265 0.322 0.018
EATING AT HOME WITH OTHERS
11. Overcome the temptation to abandon the gluten-free diet when the house is full of appetizing
food and drink.
0.086 0.072 0.655 0.406 −0.043
12. Rejecting food or a present that may contain gluten because I don’t wish to seem rude which
other people bring and invite me try.
0.139 0.037 0.585 0.537 0.054
13. When cooking a meal for others that may contain gluten and I want to join in. 0.111 0.144 0.754 0.066 0.053
14. When someone offers me something to try from their plate and which may contain gluten. 0.133 0.045 0.820 0.085 0.223
EATING OUT
15. Informing a server in a restaurant that I am a celiac sufferer when on my own. 0.877 0.239 0.097 0.124 0.095
16. Informing a server in a restaurant that I am a celiac sufferer when with friends. 0.901 0.208 0.126 0.126 0.135
17. Informing a server in a restaurant that I am a celiac sufferer in the company of others who are
not in my confidence.
0.893 0.231 0.109 0.084 0.170
18. When I want to relax and enjoy a meal in a quiet restaurant. 0.758 0.174 0.315 0.125 0.130
19. When refusing a dish that has been brought to my table in a restaurant because I think it may
not be sufficiently safe.
0.494 0.162 0.173 0.405 0.218
20. When ordering a meal in a restaurant with sufficient guarantees that it is compatible with a
gluten-free diet.
0.618 0.134 0.219 0.425 0.285
21. When I am alone, taking out and eating food I had prepared at home in case there was no
gluten-free option.
0.402 0.055 0.170 0.553 0.308
WORK OR STUDIES
22. When identifying myself as a celiac sufferer in the business or students’ meal. 0.673 0.155 0.176 0.209 0.396
23. Finding gluten-free food and drink in the work or study place. 0.353 0.242 0.168 0.176 0.717
24. Finding a gluten-free meal on a business trip or on an excursion. 0.304 0.337 0.153 0.227 0.744
25. Finding gluten-free food and drink at business or student celebrations. 0.184 0.315 0.192 0.225 0.777
Bold values show relevant items associated with each factor that was selected for the subscale.
of the variance. Lastly, factor 5, “work/studies,” explains 4.68%
of the variance. The higher the factor loading, the higher the
association of the item with the factor grouping. The highest
values for each item are shown in boldface with two exceptions:
Although item 1 “When I have to ask people to clean machines,
utensils or surfaces, for example at the butcher’s” and item 22
“When identifying myself as a celiac sufferer in the business
or students’ meal” load onto factor 1, we have considered their
second highest load to keep them in their original areas, due to
their meaning and importance in dealing with GFD and we will
wait for future studies to either eliminate them or rewrite them
and assign them to other area.
Determination of the Psychometric
Properties
In order to analyze reliability, Cronbach’s alpha was calculated
for all the areas. The scores ranged from 0.64 for “shopping” to
0.90 for “traveling,” indicating a good reliability of the structure
obtained from the factorial analysis, as can be seen in Table 3.
The alpha coefficient for the whole scale was 0.81.
The criterion validity was analyzed using the non-parametric
Spearman’s Rho correlation coefficient with the General Self-
Efficacy Scale (GSES), which was administered alongside the
questionnaire. The value was 0.279, indicating a low but
significant correlation (Table 4).
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TABLE 3 | Cronbach alpha.
Area Cronbach alpha
Shopping 0.644
Traveling 0.904
Eating at home with others 0.842
Eating out 0.858
Work or studies 0.881
TABLE 4 | Spearman’s Rho correlation coefficients.
Area Spearman’s correlation coefficient
Shopping 0.233*
Traveling 0.217*
Eating at home with others 0.166*
Eating out 0.241*
Work and studies 0.220*
Total 0.279*
*Significant in all the cases for p < 0.01.
Specific Self-Efficacy
Table 5 shows the results for specific self-efficacy for each of the
areas. The areas in which most patients have difficulties adhering
to a GFD is traveling, followed by shopping, and work. Scores
below 7 are considered to represent low self-efficacy and scores
below 5 indicate very low self-efficacy expectations. Scores below
70% of the highest score can be considered low self-efficacy. This
is a valid method for determining a cut-off point for high and
low self-scores in Likert type survey questionnaires (Child, 2006;
Hicks and McFrazier, 2014).
Differences were found for sex (p = 0.030) and for years on
GFD between those with <1 year of experience and those with
more than 5 years (p = 0.044). Differences for age were found
between the adult group and young adults group (p= 0.000) and
young adults participants and seniors (p= 0.000). No differences
were found for age at diagnosis (Table 6).
DISCUSSION
Self-efficacy expectation plays a central role in healthy habits and
adherence to treatments (DiClemente et al., 1985, 1995; Brus
et al., 1999; West et al., 1999; Lorig and Holman, 2003; Schwarzer
et al., 2008), but this has not been studied in relation to celiac
disease, in part because of the lack of specific tools to assess
self-efficacy levels. Celiac-SE fills this gap.
The Celiac-SE has good psychometric properties, both valid
and reliable in detecting specific levels of self-efficacy in celiac
disease sufferers in the main spheres of life in which they
can experience problems: eating in the workplace, shopping,
traveling, eating out, and eating at home with others. The
questionnaire is easily and quickly administered (15min at
the most) and determines the degree of specific self-efficacy
in diagnosed celiac sufferers following a life-long GFD. Its
construction followed scientific procedures in accordance with
the recommendations for constructing scales of this type
(Bandura, 2006), and was supported by the consensus of patients
and experts. A factorial analysis revealed the existence of five
factors that coincided with the areas intended to measure specific
self-efficacy for following a GFD.
The test shows a high reliability indicating that the items
are grouped around the five areas we wish to explore. The tool
presents an acceptable concurrent validity, showing positive
and significant correlations with the GSES of Baessler &
Schwarzer. Although this coefficient is significant, its low value
can be explained because the GSES scale measures general
self-efficiency, as opposed to the specific self-efficacy measured
by our scale.
Food intolerances are becoming increasingly frequent and
better diagnosed in today’s world. The tool will help patients
and professionals alike to improve the formers’ adherence to
what is, to date, the only treatment available. New intervention
models in health place emphasis on patients’ responsibility and
their empowerment to direct their treatment and improve their
quality of life (Holman and Lorig, 2000, 2004; Bodenheimer et al.,
2002; Carey and Doherty, 2012). The aim of this research was
to provide tools to study these psychosocial factors in order to
establish the bases for the design of self-management programs
for sufferers of celiac disease (Fueyo-Díaz et al., 2017).
Bandura defines expectation of self-efficacy as “the judgement
of one’s ability to organize and execute given types of
performances” (Bandura, 1997, p. 21), thus clearly distinguishing
between expectation of self-efficacy and other psychological
constructs such as feelings, outcome expectations, locus of
control, etc. Thus, this scale seeks to explore not so much feelings
andmotivations for following a GFD, but the confidence a person
has that he or she will be able to follow it. The contribution of this
questionnaire is that it makes available a tool that can measure
expectations of self-efficacy in specific situations which are real
and frequent and which have their own specific demands, as
opposed to measuring general expectation. Furthermore, the
scale provides not only a measurement of self-efficacy, but also
valuable information about its levels in the various situations
in which a celiac disease sufferer moves. From the theoretical
viewpoint, therefore, this study lies within the Social Cognitive
Theory developed by Bandura (1985) and is a first step toward
the future design of self-management programs for the disease
of the type developed by Kate Lorig (Bodenheimer et al., 2002)
at the University of Stanford. More recently, the research lines of
Schwarzer on the HAPAmodel (Schwarzer et al., 2011) propose a
more specific theoretical framework in which to interpret results
and develop self-management programs for the disease.
The levels of specific self-efficacy found in this validation study
are, in general, high. An explanation for these high scores may be
the mastery in GFD management of the sample as participants
had more than 8.77 years of experience. It seems self-efficacy
beliefs are built during the first year of experience in GFD and
reach their highest levels after 5 years on GFD. An explanation
for differences for age could be that teens are, somehow, under
parental advice at that age and it is between 18 and 35 years old
when parents transfer responsibility for the diet and they must
face the challenge for managing their diet by themselves when
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TABLE 5 | Results Celiac-SE.
Shopping Travel Eating at home with others Eating out with others Work and studies Total
Mean 8.52 7.35 9.30 8.90 8.86 8.59
Standard deviation 1.46 2.20 1.13 1.46 1.60 1.32
Percentiles 25 7.80 6.00 9.13 8.47 8.33 8.00
50 9.00 7.83 9.75 9.47 9.67 8.95
75 9.60 9.17 10.00 9.93 10.00 9.55
Cut-off point <5 3.7% 16.9% 1.4% 2.9% 3.9% 2.8%
<7 15.2% 38.3% 6.2% 9.6% 13.2% 11.5%
TABLE 6 | Results Celiac-SE by sex, age, and experience.
SEXO N Mean SD p
Male 119 8.89 1.05 0.030
Female 438 8.64 1.36
AGE GROUP
Teens <18 75 8.74 0.96
Young adults (18-35) 168 8.32 1.42
Adults (36-65) 311 8.86 1.28 0.000*
Seniors >65 8 9.70 0.24 0.000*
Total 562 8.70 1.31
YEARS ON GLUTEN FREE DIET
<1 year 35 8.11 1.86
1–3 years 131 8.68 1.30
4–5 years 80 8.67 1.30
>5 years 300 8.78 1.22 0.044**
Total 546 8.70 1.31
*Significant differences (p < 0.05) with young adults group.
**Significant differences (p < 0.05) with less than 1 year gluten free diet subjects.
shopping, traveling or at work. These results are consistent with
Social Cognitive Theory for which mastery experiences become
the most important source of self-efficacy (Bandura, 1997). These
relationships need of future research to find out if this scale would
predict GFD adherence or quality of life soon after diagnosis.
Some limitations of the study are that it has been developed
and validated in Spanish, although we do offer an English version
should other researchers wish to validated it in other settings
(Appendix). Due to its specific nature and its being closely linked
to self-efficacy expectation, it was not considered necessary to
study its test-retest reliability, although this could be studied in
the future, as could its discriminant validity. Future studies are
needed to confirm the factorial structure of the scale as well as to
consider an item reduction, e.g., eliminating items 1 or 22 if it is
confirmed they load in other factors.
In clinical settings, this scale may be useful to detect patients
with low self-efficacy expectations in dealing with GFD and that,
therefore, may show worse adherence to diet or worse quality
of life. With a cut-off point of 7 for the lowest levels of self-
efficacy, we see that around 11.5% present self-efficacy problems
inmanaging their GFDs. These are the patients who could benefit
from empowerment programs that can help them to address their
illness with lower levels of stress and better life quality.
CONCLUSION
Control of the disease through a proper GFD has a direct impact
on the celiac patients’ perceived quality of life (Casellas et al.,
2008, 2015). This tool will, in the future, enable us to explore
the expectation of self-efficacy in a specific way, and, hence, its
impact on adherence to a GFD and the subsequent quality of life.
It should also help in the design of self-management programs for
celiac disease and, with the appropriate adaptations, help other
sufferers of diseases with dietary restrictions.
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